Healthcare · Drug Manufacturers - Specialty & Generic
Laurus Labs Ltd.
LAURUSLABS
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Key metrics
Market Cap
₹59,309 cr
P/E Ratio
70.41x
P/B Ratio
13.26x
ROE
8.01%
ROCE
9.55%
Debt / Equity
0.62x
Net Margin
6.51%
Dividend Yield
15%
EPS
₹6.64
Period
FY2025